Literature DB >> 20738880

The Gln27Glu polymorphism in β2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis.

Maha H Daghestani1, Arjumand Warsy, Mazin H Daghestani, Ali N Al-odaib, Abdelmoneim Eldali, Nadia A Al-Eisa, Sabah Al-zhrani.   

Abstract

BACKGROUND: β2-adrenoceptor (β2AR) gene polymorphism glutamine 27 glutamic acid (Gln27Glu) and Arg16Gly were reported to have an association with obesity and obesity related disorders in some population. We evaluated Gln27Glu polymorphism in the β2AR gene in obese Saudi populations to investigate the association of β2AR gene with obesity and other related metabolic parameters.
DESIGN: We studied possible association of Gln27Glu in β2AR gene with body mass index (BMI), anthropometric measurements and other metabolic parameters. The β2AR gene polymorphism (Gln27Glu) was identified by sequencing PCR products representing locus of interest. Based on BMI, the subjects were divided into three groups, normal weight, overweight and obese. The genotype and allele frequency were calculated separately for each group.
RESULTS: The allelic frequency of Glu27 did not differ amongst the three groups, though the Glu27 homozygote (Glu/Glu) were more in obese subjects and had higher concentration of triglyceride, leptin and insulin compared to in the Gln27 heterozygotes and Gln/Gln homozygotes.
CONCLUSIONS: In this study we were able to provide evidence on the influence of Gln27Glu genetic variant of β2AR gene on lipid phenotypes, insulin and leptin levels in the Saudi populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738880      PMCID: PMC2940865          DOI: 10.1186/1476-511X-9-90

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  19 in total

1.  Current understanding of the etiology of obesity: genetic and nongenetic factors.

Authors:  C Bouchard
Journal:  Am J Clin Nutr       Date:  1991-06       Impact factor: 7.045

2.  Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver.

Authors:  N Iwamoto; Y Ogawa; S Kajihara; A Hisatomi; T Yasutake; T Yoshimura; T Mizuta; T Hara; I Ozaki; K Yamamoto
Journal:  Clin Chim Acta       Date:  2001-12       Impact factor: 3.786

Review 3.  Fat cell adrenergic receptors and the control of white and brown fat cell function.

Authors:  M Lafontan; M Berlan
Journal:  J Lipid Res       Date:  1993-07       Impact factor: 5.922

Review 4.  Genetic variance and lipolysis regulation: implications for obesity.

Authors:  P Arner
Journal:  Ann Med       Date:  2001-11       Impact factor: 4.709

5.  Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.

Authors:  V Large; L Hellström; S Reynisdottir; F Lönnqvist; P Eriksson; L Lannfelt; P Arner
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

6.  Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus.

Authors:  S Ishiyama-Shigemoto; K Yamada; X Yuan; F Ichikawa; K Nonaka
Journal:  Diabetologia       Date:  1999-01       Impact factor: 10.122

7.  Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.

Authors:  F Lönnqvist; H Wahrenberg; L Hellström; S Reynisdottir; P Arner
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

8.  Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects.

Authors:  Sung-Hoon Kim; Dong-Jun Kim; In Ah Seo; Yong-Ki Min; Myung-Shik Lee; Kwang-Won Kim; Moon-Kyu Lee
Journal:  Metabolism       Date:  2002-07       Impact factor: 8.694

9.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

Authors:  S A Green; J Turki; M Innis; S B Liggett
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

10.  Demonstration of an in vivo functional beta 3-adrenoceptor in man.

Authors:  S Enocksson; M Shimizu; F Lönnqvist; J Nordenström; P Arner
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more
  3 in total

1.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

2.  Arginine 16 Glycine Polymorphism in β2-Adrenergic Receptor Gene is Associated with Obesity, Hyperlipidemia, Hyperleptinemia, and Insulin Resistance in Saudis.

Authors:  Maha H Daghestani; Arjumand Warsy; Mazin H Daghestani; Ali N Al-Odaib; Abdelmoneim Eldali; Nadia A Al-Eisa; Sawsan A Omer; Zeinab K Hassan
Journal:  Int J Endocrinol       Date:  2012-09-27       Impact factor: 3.257

3.  Influence of b2 adrenergic receptor polymorphism (rs1042713 and rs1042714) on anthropometric, hormonal and lipid profiles in polycystic ovarian syndrome.

Authors:  Maha H Daghestani; Maha Omair; Mazin Daghestani; Sonya S Abdel-Razeq; Namik Kaya; Arjumand Warsy
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.